We are proud to present Intravacc’s Annual Report 2020. This report reflects a remarkable year for Intravacc, for many reasons.
2020 – a challenging and dynamic year
The year 2020 was a remarkable and challenging year for all of us around the globe. In one way or the other, we were all affected by the Covid-19 pandemic. However, for most companies in the vaccine business, this pandemic also triggered the start of an exciting period.
This was true for Intravacc, as well. During this dynamic year, we successfully continued our efforts to become a standalone private contract development and manufacturing organization (CDMO). With our state-of-the-art infrastructure, equipment, experienced staff and unique market position we are able to bridge the gap between vaccine concepts and late-stage clinical trials.